![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2022/07/Screen-Shot-2022-07-25-at-21.45.31.png)
Mekonos
Mekonos offers a chip technology to enable industrial scale genetic modification and cell editing in a safe, highly targeted, highly efficient and versatile manner. This technology is vital in the areas of cancer immunotherapy, gene engineering, and drug development.